265
Views
12
CrossRef citations to date
0
Altmetric
Review

Ulcerative colitis: prevention of relapse

, &
Pages 341-351 | Published online: 10 Jan 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Janvi Sah, Amanda Teeple, Erik Muser, Cynthia Gutierrez & Themistocles Dassopoulos. (2022) Treatment persistence and maintenance dose titration among ulcerative colitis patients on biologics: a pooled study of three United States claim databases. Current Medical Research and Opinion 38:7, pages 1093-1101.
Read now

Articles from other publishers (11)

Yongxin Luo, Shiying Liu, Huibiao Li, Jiangtao Hou, Wenjia Lin, Zewen Xu, Tianyu Lu, Yanwu Li, Bin Peng, Shijing Zhang, Xue Han, Zuoliang Kuang, Yi Wen, Jiazhong Cai, Fengbin Liu & Xin-Lin Chen. (2022) Mass Cytometry and Single-Cell Transcriptome Analyses Reveal the Immune Cell Characteristics of Ulcerative Colitis. Frontiers in Molecular Biosciences 9.
Crossref
Hiromu Morikubo, Taku Kobayashi, Ryo Ozaki, Shinji Okabayashi, Satoshi Kuronuma, Osamu Takeuchi, Tenyo Shiba, Hiroki Kiyohara, Mao Matsubayashi, Shintaro Sagami, Masaru Nakano, Osamu Ikezaki, Tadakazu Hisamatsu, Yoichi Tanaka & Toshifumi Hibi. (2021) Differential effects of mesalazine formulations on thiopurine metabolism through thiopurine S‐methyltransferase inhibition. Journal of Gastroenterology and Hepatology 36:8, pages 2116-2124.
Crossref
Makoto Naganuma, Yoko Yokoyama, Satoshi Motoya, Kenji Watanabe, Koji Sawada, Fumito Hirai, Takayuki Yamamoto, Hiroyuki Hanai, Teppei Omori, Takanori Kanai & Toshifumi Hibi. (2019) Efficacy of apheresis as maintenance therapy for patients with ulcerative colitis in an open-label prospective multicenter randomised controlled trial. Journal of Gastroenterology 55:4, pages 390-400.
Crossref
Vladislav Volarevic, Natasa Zdravkovic, Carl Randall Harrell, Nebojsa Arsenijevic, Crissy Fellabaum, Valentin Djonov, Miodrag L. Lukic & Bojana Simovic Markovic. (2019) Galectin-3 Regulates Indoleamine-2,3-dioxygenase-Dependent Cross-Talk between Colon-Infiltrating Dendritic Cells and T Regulatory Cells and May Represent a Valuable Biomarker for Monitoring the Progression of Ulcerative Colitis. Cells 8:7, pages 709.
Crossref
Ji Young Chang, Jae Hee Cheon, Yehyun Park, Soo Jung Park, Tae-Il Kim & Won-Ho Kim. (2018) Does Medical Acceleration Improve Outcomes in Ulcerative Colitis Patients Who Are in Clinical Remission but Have Endoscopic Inflammation?. Digestive Diseases and Sciences 63:11, pages 3041-3048.
Crossref
Kiyoto MoriMakoto NaganumaShinta MizunoHiroaki SuzukiMina T. KitazumeKatsuyoshi ShimamuraSayako ChibaAkira SugitaKatsuyoshi MatsuokaTadakazu HisamatsuTakanori Kanai. (2018) β-(1,3)-Glucan derived from Candida albicans induces inflammatory cytokines from macrophages and lamina propria mononuclear cells derived from patients with Crohn's disease . Intestinal Research 16:3, pages 384.
Crossref
Makoto Naganuma, Shinta Mizuno, Kosaku Nanki, Shinya Sugimoto & Takanori Kanai. (2016) Recent trends and future directions for the medical treatment of ulcerative colitis. Clinical Journal of Gastroenterology 9:6, pages 329-336.
Crossref
Shinya Sugimoto, Makoto Naganuma & Takanori Kanai. (2016) Indole compounds may be promising medicines for ulcerative colitis. Journal of Gastroenterology 51:9, pages 853-861.
Crossref
David T. Rubin, Marc Bradette, Libor Gabalec, Daniela Dobru, Juan Márquez, Susi Inglis, Elizabeth Magee, Dory Solomon & Geert D’Haens. (2016) Ulcerative Colitis Remission Status After Induction With Mesalazine Predicts Maintenance Outcomes: the MOMENTUM Trial. Journal of Crohn's and Colitis 10:8, pages 925-933.
Crossref
Stephen B. Hanauer & Daniel K. Podolsky. 2015. Yamada' s Textbook of Gastroenterology. Yamada' s Textbook of Gastroenterology 1378 1417 .
Kosaku Nanki, Makoto Naganuma, Shinta Mizuno, Katsuyoshi Matsuoka & Takanori Kanai. (2015) Bacteriotherapy reintroduces “old friends” in IBD. Inflammation and Regeneration 35:3, pages 122-128.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.